Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
Investment demonstrates confidence in America’s commitment to science and innovation
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
PRX-PLUS has a unique product feature with its deep-impacting formula
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Subscribe To Our Newsletter & Stay Updated
